DJIA 17,751.39 121.12 0.69%
NASDAQ 5,111.73 22.53 0.44%
S&P 500 2,108.57 15.32 0.73%
market minute promo

Emergent BioSolutions (NYSE: EBS)

company name or ticker

Health Care Sector Update for 02/13/2015: GSK, EBS, CPHD

Emergent BioSolutions Provides Preliminary 2014 Results - Analyst Blog

Emergent BioSolutions Buys EV-035 Series from Evolva - Analyst Blog

3 Fast-Growing Biotech Stocks To Buy in December

You don't want to miss out on these tiny biotechs expected to see earnings grow sharply in 2015.

Worried About a Market Crash? These 3 Stocks Soared During the Great Recession

Catamaran Corp., Cantel Medical, and Emergent BioSolutions all gained ground during the Great Recession, suggesting that they might be good stocks to watch if markets head south.

Emergent BioSolutions Beats on Q3 Earnings, Guidance Up - Analyst Blog

Emergent BioSolutions Inc Busts Through Guidance. Sort of.

Emergent BioSolutions' upfront payment from its deal with MorphoSys caused a large increase in revenue in the third quarter.

Emergent BioSolutions' (EBS) CEO Dan Abdun-Nabi on Q3 2014 Results - Earnings Call Transcript

Emergent BioSolutions (EBS) Q3 2014 Results - Earnings Call Webcast

Ebola: The making of a $1 billion drug

See More Articles...